Lv72
3990 积分 2024-01-22 加入
First-Line Sugemalimab Plus Chemotherapy for Advanced Gastric Cancer
1个月前
已完结
Trastuzumab-Deruxtecan: Redefining HER2 as a Tumor Agnostic Biomarker
1个月前
已完结
Exploring DESTINY: the Past, Present, and Future of Trastuzumab Deruxtecan
1个月前
已完结
Sacituzumab Govitecan Demonstrates Efficacy across Tumor Trop-2 Expression Levels in Patients with Advanced Urothelial Cancer
3个月前
已完结
Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer
3个月前
已完结
Efficacy and Safety of Belimumab in Patients With Lupus Nephritis: Subgroup Analyses of a Phase 3 Randomized Trial in the East Asian Population
5个月前
已完结
Effect of Rituximab on Serum Levels of Anti-C1q and Antineutrophil Cytoplasmic Autoantibodies in Refractory Severe Lupus Nephritis
5个月前
已完结
The frequency of low HER2 expression in breast cancer and a comparison of prognosis between patients with HER2-low and HER2-negative breast cancer by HR status
5个月前
已完结
The genomic landscape of lung adenocarcinoma—insights towards personalized medicine
6个月前
已关闭
The prevalence of EGFR mutations in non‐small cell lung cancer in an unselected Caucasian population
6个月前
已完结
皖公网安备34019202002308
